Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
22.15
+0.06 (0.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Elanco Animal Health stock have an average target of 27.89, with a low estimate of 23 and a high estimate of 30. The average target predicts an increase of 25.91% from the current stock price of 22.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 5 | 6 | 7 | 7 | 7 | 6 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +35.44% | Apr 15, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +8.35% | Feb 25, 2026 |
| Keybanc | Keybanc | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +30.93% | Feb 25, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +35.44% | Feb 24, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $28 | Buy | Maintains | $24 → $28 | +26.41% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
5.10B
from 4.72B
Increased by 8.21%
Revenue Next Year
5.37B
from 5.10B
Increased by 5.31%
EPS This Year
1.05
from -0.47
EPS Next Year
1.19
from 1.05
Increased by 13.49%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.3B | 5.6B | ||||||
| Avg | 5.1B | 5.4B | ||||||
| Low | 4.9B | 5.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.7% | 9.5% | ||||||
| Avg | 8.2% | 5.3% | ||||||
| Low | 3.5% | -0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.11 | 1.30 | ||||||
| Avg | 1.05 | 1.19 | ||||||
| Low | 0.98 | 1.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 23.7% | ||||||
| Avg | - | 13.5% | ||||||
| Low | - | 5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.